We have observed
1 EP application
Antonio Di Donato
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 20, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Peptidic and non peptidic ligands for immunodetection of the receptor for urotensin II